Game-Changing Company Tracker - Google DeepMind Health - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Game-Changing Company Tracker - Google DeepMind Health" report to their offering.

Acquired by Google in 2014, DeepMind is leveraging artificial intelligence-based machine learning technology to solve some of the biggest problems in healthcare such as early diagnosis of life-threatening conditions including cancer and diabetes. DeepMind is partnering with NHS at various levels to address healthcare issues.

This includes patient data sharing agreements for research on early detection of diabetic retinopathy-induced blindness by analyzing anonymized digital eye scans.

Key Topics Covered:

1. Game-Changing Company Tracker-Google DeepMind Health

2. Executive Summary

- Key Findings

- Game-Changing Company Tracker Objectives

3. Artificial Intelligence Approach to Disease Diagnosis and Treatment

- Google DeepMind Overview

- Potential Impact to Market

- Legal Disclaimer

For more information about this report visit http://www.researchandmarkets.com/research/h78drt/gamechanging

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716